Mark Kirschbaum
Overview
Mark Kirschbaum received an average of $563K in total compensation, including $299K in salary, at Cyclacel Pharmaceuticals from 2020 to 2023.
2023Cyclacel PharmaceuticalsFormer Senior Vice President and Chief Medical Officer
2022Cyclacel PharmaceuticalsSenior Vice President and Chief Medical Officer
2021Cyclacel PharmaceuticalsSenior Vice President and Chief Medical Officer
2020Cyclacel PharmaceuticalsSenior Vice President and Chief Medical Officer
Source: SEC filings on May 7, 2024, April 28, 2023, April 26, 2022, and April 29, 2021.
Related executives
We found eight more executives who work or worked at Cyclacel Pharmaceuticals.
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
Robert Jackson
Cyclacel Pharmaceuticals
Chief Scientific Officer
Robert Kirkman
Cyclacel Pharmaceuticals
Chief Executive Officer
Kathi Cordova
Cyclacel Pharmaceuticals
Former Senior Vice President of Finance and Treasurer
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021